(19)
(11)
EP 0 835 104 A1
(12)
(43)
Date of publication:
15.04.1998
Bulletin 1998/16
(21)
Application number:
96923579.0
(22)
Date of filing:
28.06.1996
(51)
International Patent Classification (IPC):
C07D
207/
50
( . )
A61K
31/
165
( . )
A61K
31/
192
( . )
A61K
31/
40
( . )
A61K
31/
437
( . )
A61K
31/
546
( . )
A61P
7/
06
( . )
C07D
495/
22
( . )
C07K
14/
47
( . )
A61K
31/
12
( . )
A61K
31/
166
( . )
A61K
31/
195
( . )
A61K
31/
435
( . )
A61K
31/
50
( . )
A61K
45/
00
( . )
C07D
495/
14
( . )
C07D
501/
36
( . )
(86)
International application number:
PCT/US1996/011158
(87)
International publication number:
WO 1997/002024
(
23.01.1997
Gazette 1997/05)
(84)
Designated Contracting States:
BE CH DE ES FR GB IT LI NL
(30)
Priority:
30.06.1995
US 19950497357
08.02.1996
US 19960598715
(71)
Applicant:
SMITHKLINE BEECHAM CORPORATION
King of Prussia, PA 19406-0939 (US)
(72)
Inventor:
DUNNINGTON, Damien, John
Lafayette Hill, PA 19444 (US)
(74)
Representative:
Waters, David Martin, Dr., et al
Smithkline Beecham plc Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)
(54)
USE OF STAT 5 SH2 DOMAIN SPECIFIC COMPOUNDS TO ENHANCE ERYTHROPOIESIS